CAR-T Therapy: An Emerging Treatment for MS

Sponsored by Bristol Myers Squibb & Kyverna

7 Nov 2024 | ~54:40 Engagement Time

Presenters

Gregory Wu , MD, PhD, FAAN

On This Page

Related Resources

Hope in Innovation: Exploring CAR-T Cell Therapy for MS

Gregory Wu , MD, PhD, FAAN & Stephanie Buxhoeveden , PhD, MSCN, MSN, FNP-BC

Text reads: Exploring CAR-T Cell Therapy in Multiple Sclerosis: What You Need to Know

Exploring CAR-T Cell Therapy in Multiple Sclerosis: What You Need to Know

Robert Bermel , Neurologist

Webinar Recording

Overview

Watch this webinar to learn about CAR-T therapy, an emerging treatment for relapsing and progressive MS. Through the use of bio-engineering technology, CAR-T therapy removes t-cells from your immune system and turns them into CAR-T cells. When re-introduced into your immune system these CAR-T cells target the B cells that cause inflammation and damage in MS. Tune in to learn what this means for you and the treatment of your MS.

Thank you to our generous sponsors Bristol Myers Squibb and Kyverna.